Quick View
| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥300.0B | ¥256.4B | +17.0% |
| Operating Income | ¥39.8B | ¥31.3B | +27.3% |
| Equity-Method Investment Gain/Loss | - | - | - |
| Ordinary Income | ¥41.4B | ¥32.8B | +26.3% |
| Net Income | ¥28.5B | ¥22.8B | +25.2% |
| ROE (Annualized) | 15.6% | 12.8% | - |
Executive Summary
The key feature of this earnings result is that operating income growth exceeded revenue growth, resulting not only in higher revenue and profit but also simultaneous improvement in profitability. Revenue was ¥300.0B (+17.0% YoY), operating income was ¥39.8B (+27.3%), ordinary income was ¥41.4B (+26.3%), and net income was ¥28.5B (+25.2%). Supported by an improved gross margin and a lower SG&A ratio, the operating margin expanded to 13.3%, approximately 107bp above 12.2% in the same period of the previous year.
Factors Affecting Earnings
【Revenue】Revenue was ¥300.0B, an increase of +17.0% YoY. The reported business consists of a single wholesale segment covering the laboratory, industrial, and medical and nursing care fields; segment disclosure is not provided because the businesses have similar characteristics. This represents a pace substantially above the full-year company forecast of 6.5% revenue growth, indicating a strong start to growth in Q1.
【Profit and Loss】Cost of sales increased +16.7% YoY to ¥207.3B, remaining nearly in line with revenue growth, while the gross margin improved slightly to 30.9% from 30.7% in the previous year. SG&A expenses were ¥52.9B (+11.2%), below the rate of revenue growth, and the SG&A ratio declined to 17.6% from 18.5%. As a result, operating income increased +27.3% to ¥39.8B, exceeding the revenue growth rate and demonstrating operating leverage. Non-operating income and expenses resulted in a surplus of ¥1.6B, including ¥0.9B in dividend income, and had a limited impact on ordinary income. Extraordinary losses were also minimal at ¥0.01B, consisting of losses on disposal of fixed assets, indicating that the increase in profit was primarily driven by the core business. Overall, the company achieved higher revenue and profit, representing high-quality earnings growth accompanied by improved cost efficiency.
Key Financial Metrics
【Profitability】The operating margin was 13.3%, improving by approximately 107bp from 12.2% in the same period of the previous year, while the net margin also rose to 9.5% from 8.9%. The primary driver of the improvement was the decline in the SG&A ratio (-91bp), rather than the modest increase in gross margin (+16bp), indicating that operating leverage from the absorption of fixed costs is taking effect.【Cash Flow Quality】DSO, calculated based on the total of trade receivables (accounts receivable of ¥214.5B and electronically recorded monetary claims of ¥157.4B), was 65 days, exceeding 60 days and warranting continued monitoring of the collection cycle. Meanwhile, inventories increased +6.3% YoY, below revenue growth of +17.0%, with no excessive inventory buildup observed.【Investment Efficiency】Annualized ROE was 15.6%. Its decomposition into a net margin of 9.5%, total asset turnover of 1.14x, and financial leverage of 1.44x confirms that ROE is primarily driven by profitability.【Financial Soundness】The equity ratio remained high at 69.5%, and the current ratio was also high. However, short-term borrowings rose from ¥21.2B in the previous year to ¥45.1B, an increase of +112.5%, while long-term borrowings increased from ¥26.3B to ¥46.3B, up +76.2%. The purpose of financing and changes in the borrowing structure therefore require monitoring.
Cash Flow Analysis
Because the available data do not include cash flow statement items, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥229.6B, increasing from ¥200.4B in the same period of the previous year, suggesting that cash generation from operations remains ongoing. Meanwhile, short-term borrowings increased from ¥21.2B to ¥45.1B, and long-term borrowings increased from ¥26.3B to ¥46.3B, resulting in an overall expansion of interest-bearing debt. The simultaneous increase in cash and borrowings may indicate that financing is being raised for growth investments and the buildup of working capital, including inventories and receivables. The equity ratio remained high at 69.5%, and the stability of the financial structure has been maintained even after the increase in borrowings.
Earnings Quality
The increase in net income to ¥28.5B was primarily attributable to the expansion of operating income from the core business, with limited reliance on non-recurring factors. Extraordinary losses consisted solely of ¥0.01B in losses on disposal of fixed assets, while the difference between ordinary income and net income was primarily due to income taxes and other taxes (¥12.9B, representing an effective tax rate of approximately 31%). Non-operating income of ¥2.4B consisted mainly of ¥0.9B in dividend income and other items, accounting for only approximately 0.8% of revenue; the core of earnings remains the primary business. Comprehensive income was ¥44.5B, exceeding net income of ¥28.5B, with the difference resulting from increases of ¥15.0B in valuation difference on securities and ¥0.9B in foreign currency translation adjustments. This divergence reflects temporary valuation factors based on market price fluctuations and should be distinguished from the underlying earnings power of business operations.
Earnings Forecast and Guidance
The full-year company forecasts are revenue of ¥1178.5B (+6.5% YoY), operating income of ¥129.0B (+0.5%), and ordinary income of ¥133.5B (+0.9%), with no revisions to either the earnings forecast or the dividend forecast. Q1 progress toward the full-year forecasts was 25.5% for revenue, 30.9% for operating income, 31.0% for ordinary income, and 31.8% for net income, all exceeding the standard quarterly progress rate of 25%. In particular, the fact that progress on profit exceeded progress on revenue indicates that the high profit growth rate in Q1 is ahead of the full-year plan. However, because the full-year profit growth forecast remains modest at +0.5%, the company appears to have incorporated a degree of caution regarding gross margin, the SG&A ratio, and demand trends from Q2 onward. The sustainability of the pace of progress in subsequent quarters will therefore be a key point for confirmation.
Shareholder Returns
The full-year dividend forecast is ¥66.00 per share, and forecast EPS is ¥125.86, implying a payout ratio of 52.4%. There has been no revision to the dividend forecast, and the payout ratio is below the 60% level generally regarded as an indication of sustainability. Given the financial foundation of an equity ratio of 69.5% and cash and deposits of ¥229.6B, the current dividend plan is consistent with earnings progress. No information regarding share repurchases can be confirmed from the data.
Risk Factors
-
Lengthening collection period for trade receivables: DSO is 65 days, exceeding 60 days. Changes in the aggregate balance and collection terms of accounts receivable of ¥214.5B and electronically recorded monetary claims of ¥157.4B affect working capital efficiency under the wholesale business model.
-
Increase in borrowings and refinancing terms: Short-term borrowings increased sharply by +112.5% YoY, while long-term borrowings increased +76.2%. Although the short-term liabilities ratio is high at approximately 49%, cash and deposits of ¥229.6B, net cash of approximately ¥138B, and high interest coverage provide a buffer. Continued monitoring of the purpose and terms of the increased borrowings is required.
-
Maintenance of the gross margin and SG&A ratio: The improvement in the operating margin (+107bp) is supported by both a modest increase in the gross margin and a decline in the SG&A ratio. If the gross margin declines due to changes in procurement prices, the competitive environment, or the sales mix, achievement of the full-year operating income plan (+0.5% YoY) could be affected.
Industry Benchmark (Reference, Company Analysis)
Industry Benchmark (trading)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 13.3% | 4.3% (1.7%–6.9%) | +9.0pt |
| Net Margin | 9.5% | 3.8% (1.5%–5.1%) | +5.7pt |
Both the operating margin and net margin are substantially above the industry median, placing the company among the more profitable companies in the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 17.0% | 3.1% (-0.6%–11.7%) | +13.9pt |
The revenue growth rate is substantially above the industry median, representing a top-tier growth pace within the industry.
※Source: Company analysis
Key Points in the Earnings Results
-
Operating income increased 27.3% against revenue growth of 17.0%, with operating leverage accompanied by a decline in the SG&A ratio (-91bp) serving as the structural driver of the improvement in the profit margin.
-
Q1 progress toward the full-year forecast was 30.9% for operating income and 31.8% for net income, exceeding the standard pace. However, the full-year operating income forecast remains at only +0.5% YoY, making gross profit and SG&A trends from Q2 onward the determining factors for achievement of the plan.
-
DSO of 65 days and the +112.5% increase in short-term borrowings warrant continued monitoring even amid the strong financial foundation represented by an equity ratio of 69.5% and net cash of approximately ¥138B.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥1,114 |
| base | ¥1,127 |
| bull | ¥1,151 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,027 |
| Adjusted Forecast EPS | ¥130.5 |
| Cost of Equity r | 9.27% (10-year JGB 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 52.4% |
| Forecast EPS Confidence Adjustment | ×1.037 (based on the track record of guidance achievement in the same industry) |
| implied PBR / PER | 1.10x / 8.6x |
Sensitivity: ¥1,097–¥1,160 at ±1% in the cost of equity, and ¥1,125–¥1,131 at ±0.1 in ω.
Notes:
- Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
- Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.
---End of Report---